-
Entry BC Medication Administration (2.16.840.1.113883.3.1818.10.4.36)
-
Entry CDA ManufacturedProduct (2.16.840.1.113883.10.12.312)
-
Entry CDA LabeledDrug (2.16.840.1.113883.10.12.310)
-
Entry CDA Material (2.16.840.1.113883.10.12.311)
-
* CDA Organization (2.16.840.1.113883.10.12.151)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.1937.777.17.10.2)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
* CDA Organization (2.16.840.1.113883.10.12.151)
-
Entry BC Location Participant (Body) (2.16.840.1.113883.3.1818.10.4.13)
-
Entry BC Location PlayingEntity (2.16.840.1.113883.3.1937.777.17.10.14)
-
Entry BC Comment Observation (2.16.840.1.113883.3.1818.10.4.3)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.1937.777.17.10.2)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
* CDA Organization (2.16.840.1.113883.10.12.151)
|